David McIntosh: A Medico-Scientific Challenge
David McIntosh, Founder and Chair of United Plasma Action, shared a post on LinkedIn:
”A Medico-Scientific Challenge …
Following on from the recent UPA ‘Reflections’ post, it occurs to me that some friends and colleagues – and even perhaps some argumentative adversaries – might like to rise to a little challenge ……
It is this -please try to draft the most convincing explanation you can think of as to why the licensed plasma-derived medicines listed in black in the attached document are NOT safe to make from UK donors’ plasma along with a parallel explanation/justification as to why the medicines shown in green ARE safe to make from our plasma.
I admit that in scientific terms, this is almost certainly a genuinely impossible task; but as a challenge in satirical script-writing it’s surely well worth a try ….”

Other posts featuring David McIntosh on Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines